Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: Indications for staging laparoscopy.
Summary of "Predicting factors of unexpected peritoneal seeding in locally advanced gastric cancer: Indications for staging laparoscopy."
BACKGROUND AND
OBJECTIVES:
The aim of this study is to investigate predictive factors for unexpected peritoneal seeding from clinically resectable advanced gastric cancers to suggest the indications for staging laparoscopy (SL).
METHODS:
A total of consecutive 589 gastric cancer patients who were clinically diagnosed with advanced gastric cancer with no metastatic disease underwent operations at Seoul St. Mary's Hospital.
RESULTS:
A total of 72 patients (including 35 patients with seeding to distant peritoneum) were surgically diagnosed with peritoneal seeding. Borrmann type 3 (
OR:
4.475) or type 4 (
OR:
8.243) cancer, tumor invasion of T3 (
OR:
2.794) or T4 (
OR:
6.841) and tumor size (4 cm OR:
3.723 and 8 cm OR:
6.971) were predictive factors for overall peritoneal seeding. Borrmann type 3 (
OR:
3.524) or 4 (
OR:
4.695) cancer, tumor invasion of T3 (
OR:
4.378) or T4 (
OR:
15.817), and tumors involving the anterior wall (
OR:
2.762) also turned out to be predictive factors for distant peritoneal seeding.
CONCLUSIONS:
If SL were performed by these predictive factors, this should have been performed in 42.4% of advanced gastric cancers and the detection rates for overall peritoneal seeding would have been 24.0%. J. Surg. Oncol. (c) 2010 Wiley-Liss, Inc.
Affiliation
Department of Surgery, Ajou University, School of Medicine, Suwon, Korea.
Journal Details
This article was published in the following journal.
Name: Journal of surgical oncology
ISSN: 1096-9098
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/20812349
- DOI: http://dx.doi.org/10.1002/jso.21685
Medical and Biotech [MESH] Definitions
Peritoneal Dialysis, Continuous Ambulatory
Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution.
Peritoneal Fibrosis
Disorder characterized by a wide range of structural changes in PERITONEUM, resulting from fibrogenic or inflammatory processes. Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency.
Peritoneal Stomata
Natural openings in the subdiaphragmatic lymphatic plexus in the PERITONEUM, delimited by adjacent mesothelial cells. Peritoneal stomata constitute the principal pathways for the drainage of intraperitoneal contents from the PERITONEAL CAVITY to the LYMPHATIC SYSTEM.
Gastric Dilatation
Abnormal distention of the STOMACH due to accumulation of gastric contents that may reach 10 to 15 liters. Gastric dilatation may be the result of GASTRIC OUTLET OBSTRUCTION; ILEUS; GASTROPARESIS; or denervation.
Peritoneal Lavage
Washing out of the peritoneal cavity. The procedure is a diagnostic as well as a therapeutic technique following abdominal trauma or inflammation.
PubMed Articles
Indications for Staging Laparoscopy in Clinical T4M0 Gastric Cancer.
BACKGROUND: This study was undertaken to determine the efficacy of the clinical indications for performing staging laparoscopy for locally advanced gastric cancer to detect perit...
PURPOSE: It is well known that CPT-11 (irinotecan) is biotransformed to its active metabolite, SN-38, by carboxylesterase in the liver and other tissues. However, little is known about its pharmacokin...
Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer.
Patients with advanced gastric carcinoma, especially peritoneal dissemination, have a poor prognosis. Various treatments have been used for peritoneal dissemination of gastric cancer, but there is no...
Clinical Implication of Serosal Change in Pathologic Subserosa-Limited Gastric Cancer.
BACKGROUND: The aim of this study was to evaluate the clinical implication of serosal change in pathologic subserosa-limited gastric cancer based on a retrospective analysis....
BACKGROUND: The peritoneum is still the most frequent site of recurrence in stage II/III gastric cancer patients, although the survival rate was improved by the introduction of S...
Clinical Trials
Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers
The purpose of this study is to evaluate the efficacy,response rate,time to treatment failure,overall survival,toxicities of Paclitaxel-HDFL regimen in locally advanced/inoperable and recu...
Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples
We are undertaking a study of patients with gastric or pancreatic cancer. A common place for cancer to return after surgery for gastric or pancreatic cancer is the inside lining of the abd...
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
To develop effective chemotherapy regimen against gastric cancer with peritoneal metastasis
The Factors Predicting Change of Peritoneal Transport Characters in Peritoneal Dialysate
Peritoneal fibrosis (PF) is one of the most serious complications after long-term continuous ambulatory peritoneal dialysis (CAPD). Human peritoneal fibroblast (HPFB) and extracellular mat...
Rationale: Diagnostic procedures, such as MRI, may help doctors predict a patient's response to treatment and help plan the best treatment. Purpose: This clinical trial is studying MRI in...
